CMS Expects No Significant Change In Average Sales Prices Before 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency’s final 2005 Physician Fee Schedule includes a second round of preliminary ASPs, with data for a larger number of drugs than in the proposed rule. Final average sales prices for the first quarter of 2005 will be published in December.
You may also be interested in...
Medicare Part B ASP Cost Savings Fall Below Government Expectations, Lawyer Says
Congress is considering methods to improve cost savings from Part B reimbursement, Sidley Austin attorney says at International Pharmaceutical Compliance Summit in Philadelphia. Analysts note that the full impact of the average sales price-based Part B reimbursement is not yet evident.
Medicare Part B ASP Cost Savings Fall Below Government Expectations, Lawyer Says
Congress is considering methods to improve cost savings from Part B reimbursement, Sidley Austin attorney says at International Pharmaceutical Compliance Summit in Philadelphia. Analysts note that the full impact of the average sales price-based Part B reimbursement is not yet evident.
Medicaid Reform Must Decrease Drug Prices For States – HHS Secretary
States should pay "the same low rate" for drugs as pharmacies and Medicare, Secretary Leavitt says. Reforms could save the federal government $15 bil. and the states $11 bil. over the next 10 years; details will be outlined in the President's forthcoming fiscal year 2006 budget request.